---
title: "Alopexx (ALPX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ALPX.US.md"
symbol: "ALPX.US"
name: "Alopexx"
industry: "Infectious Disease Biopharmaceuticals"
---

# Alopexx (ALPX.US)

| Item | Detail |
|------|--------|
| Industry | Infectious Disease Biopharmaceuticals |

## Company Profile

Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA.

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/ALPX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ALPX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ALPX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.